A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study
| Status: | Completed |
|---|---|
| Conditions: | Psoriasis |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 12 - Any |
| Updated: | 5/5/2017 |
| Start Date: | April 2015 |
| End Date: | January 2016 |
A Randomized Double Blind Vehicle Controlled Dose Ranging Multiple Site Phase 2 Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Moderate to Severe Scalp Psoriasis
The objectives of this study are to evaluate the therapeutic efficacy and safety of DSXS and
a Placebo in patients with moderate to severe scalp psoriasis.
a Placebo in patients with moderate to severe scalp psoriasis.
This randomized, double-blind, vehicle-controlled, dose-ranging, parallel-group multi-site
study is designed to evaluate the therapeutic efficacy and safety of the investigational
product, DSXS, for the treatment of moderate to severe scalp psoriasis at different
application times up to 30 minutes.
study is designed to evaluate the therapeutic efficacy and safety of the investigational
product, DSXS, for the treatment of moderate to severe scalp psoriasis at different
application times up to 30 minutes.
Inclusion Criteria:
- Male or non-pregnant, non-lactating females age 12 and older.
- Clinical diagnosis of moderate to severe scalp psoriasis, defined by a Investigator's
Global Assessment score of at least 3 at screening.
Exclusion Criteria:
- Under 12 years of age.
- Patients whose scalp and/or non-scalp psoriasis necessitates systemic or other
concomitant topical therapies during the study.
- Has a scalp skin condition that would interfere with the diagnosis or assessment of
plaque psoriasis of the scalp.
We found this trial at
1
site
Click here to add this to my saved trials
